VetOncoRx
Manufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
37 Crescent Rd, Millbrook, New York, 125...Phone Number
(917) 608-1853Website
www.vetoncorx.comRevenue
<$5 MillionIndustry
About VetOncoRx
VetOncoRx Org Chart
Is VetOncoRx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check if VetOncoRx has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when VetOncoRx launches new products
Check out if VetOncoRx is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at VetOncoRx
Earning: See what the market has to say on VetOncoRx recently announced quarterly report
VetOncoRx, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if VetOncoRx had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once VetOncoRx has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to VetOncoRx
Compare insights from companies similar to VetOncoRx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
VetOncoRx is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
VetOncoRx is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about VetOncoRx.
VetOncoRx Tech Stack
A closer look at the technologies used by VetOncoRx
Top Manufacturing Companies
Frequently Asked Questions Regarding VetOncoRx
VetOncoRx, Inc. is a biopharmaceutical company dedicated to developing innovative treatments for canine cancers such as hemangiosarcoma, melanoma, and osteosarcoma. The company adapts preclinical drugs originally designed for humans to target similar afflictions in dogs, working closely with the Animal & Veterinary branch of the FDA for development... Read More